ArticleBlood cancer journal2026

Circulating CD20-positive extracellular vesicles impair rituximab efficacy and predict outcomes in diffuse large B-cell lymphoma.

Bon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.